// App-Quantinova.ai

Abstract 10135 : Cardiotoxicity and Mortality in Chimeric Antigen Receptor T Cell Therapy Recipients

Researchers

Presenter

  • Syed S Mahmood

Principal Investigators

  • Stephanie Feldman

  • Jennifer Liu

  • Gina George

  • Stephen A Sansoterra

  • Elena Mead

  • Thomas Althaus

  • Lauren Balkan

  • Tarek A Barbar

  • Katherine Lee Chuy

  • Bhisham Harchandani

  • Miguel Perales

  • Mark Geyer

  • Jae Park

  • M L Palomba

  • Roni Shouval

  • Ana A ALARCON TOMAS

  • Eric Yang

  • Daria L Gaut

  • Raza Alvi

  • Michael Rothberg

  • Jonathan W Weinsaft

  • Richard B Devereux

  • Evelyn M Horn

  • John P Leonard

  • Koen van Besien

  • Tomas G Neilan

  • Richard Steingart

Medical Centers

  • Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY

  • Cornell University, Ithaca, NY

  • Weill Cornell, New York, NY

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • David Geffen School of Medicine at UCLA,Los

  • Division of Hematology/Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY

  • Weill Cornell Medicine, New York, NY

  • Medicine/Cardiology, Weill Cornell Medicine, New York, NY

  • Memorial Sloan Kettering, New York, NY

  • Adult BMT Service, Dept of Medicine, Memorial Sloan Kettering Cancer Cntr, New York, NY

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY

  • Div of Hematology/Oncology, Dept of Medicine, Univ of California Los Angeles, Los Angeles, CA

  • MASS GENERAL HOSPITAL, Boston, MA

  • Weill Cornell Med College, Scarsdale, NY

  • UCLA MEDICAL CENTER, Culver City, CA

  • Hematopoietic Cellular Therapy Program, Section of Hematology/Oncology, Dept of Medicine, Univ of Chicago, Chicago, IL

  • Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Cntr, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Cardiovascular (CVS)

Disease

  • Acute lymphoblastic leukemia

  • Cardiotoxicity

  • Lymphomas

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved